SHAKERA HEADLEY: Open Payments
NPI 1831805001 · HARWICH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 46 payments from 18 companies in 2025. Trend: 2023 $113 · 2024 $781 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $228 |
| BETA BIONICS, INC. | 2 | $102 |
| Sequel Med Tech, LLC | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| Lilly USA, LLC | 3 | $60 |
| Novo Nordisk Inc | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Soleno Therapeutics, Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Radius Health, Inc. | 1 | $33 |
Products named: EVENITY, iLet Bionic Pancreas, TWIIST, Kerendia, MOUNJARO, Wegovy, VYKAT XR, LEQVIO.
Industry payments across MA — which companies pay providers there.
